Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04202354
What this trial is testing

Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Who this might be right for
Non-alcoholic Steatohepatitis
Arrowhead Pharmaceuticals 50
Testing effectiveness (Phase 2)Looking for participantsNCT06477146
What this trial is testing

Milk Thistle Clinical Trial in Pediatric NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)
University Hospitals Cleveland Medical Center 20
Post-approval studies (Phase 4)UnknownNCT03648554
What this trial is testing

Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Central Hospital, Nancy, France 93
Post-approval studies (Phase 4)UnknownNCT00941642
What this trial is testing

Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Huntington Medical Research Institutes 40
Not applicableStudy completedNCT06933745
What this trial is testing

Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study

Who this might be right for
Cardiovascular DiseasesFatty LiverAtherosclerosis of Femoral Artery+4 more
University Hospital, Akershus 21,029
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableStudy completedNCT05259475
What this trial is testing

Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Institute for Human Development and Potential (IHDP), Singapore 90
Not applicableWithdrawnNCT03538236
What this trial is testing

Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH

Who this might be right for
ObesityNASH - Nonalcoholic SteatohepatitisObesity, Morbid
Johns Hopkins University
Not applicableUnknownNCT00152711
What this trial is testing

Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis

Who this might be right for
Sleep Apnea SyndromeNonalcoholic Steatohepatitis
University Hospital, Angers 40
Not applicableActive Not RecruitingNCT06240039
What this trial is testing

Direct Versus Indirect Effect of Amino Acids on Hepatokines

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
University of Copenhagen 30
Not applicableUnknownNCT04918732
What this trial is testing

NAFLD Primary Care

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseCardiovascular DiseasesType2 Diabetes+2 more
Maastricht University 1,470
Not applicableLooking for participantsNCT06335771
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

Who this might be right for
ObesityNonalcoholic Fatty LiverDiabetes Type 2+1 more
Bettina Mittendorfer 60
Testing effectiveness (Phase 2)Ended earlyNCT03467217
What this trial is testing

Losartan for the Treatment of Pediatric NAFLD

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 83
Testing effectiveness (Phase 2)Study completedNCT02330549
What this trial is testing

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD

Who this might be right for
Prediabetic StateNon-alcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
Tobira Therapeutics, Inc. 45
Not applicableNot Yet RecruitingNCT06135584
What this trial is testing

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
The Affiliated Hospital of Hangzhou Normal University 1,000
Early research (Phase 1)Study completedNCT02891408
What this trial is testing

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 74
Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Testing effectiveness (Phase 2)UnknownNCT05622526
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Patients With Nonalcoholic Steatohepatitis
Instituto de Investigación Marqués de Valdecilla 96
Testing effectiveness (Phase 2)Study completedNCT01792115
What this trial is testing

Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
Testing effectiveness (Phase 2)Looking for participantsNCT06798948
What this trial is testing

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Who this might be right for
Metabolic-associated Fatty Liver Disease (MAFLD)
Li Lab,MD 100
Next Page